All News

Typically, a consultant is brought into a urology practice for a particular project such as conducting an operational assessment, but just as importantly, once the consultant has gained this familiarity with the practice, he/she makes a great mentor.

The AUA has released its first-ever clinical practice guideline for castration-resistant prostate cancer, and all urologists who care for men with advanced prostate cancer should familiarize themselves with its contents, said Michael S. Cookson, MD, who presented the new guideline at the AUA annual meeting in San Diego.

Resources to help you understand the current state of the urology work force, including trends specific to your county, and future projections. Watch for updates to this page as they become available!

Lenox Hill Hospital, New York has announced the appointment of David B. Samadi, MD, as chair of urology at Lenox Hill Hospital and professor of urology at the Hofstra North Shore-Long Island Jewish School of Medicine, Hempstead, NY.

The recent completion of the AUA’s Guideline on Castration-Resistant Prostate Cancer was not only timely but also very important for those of us treating these patients.

Recent studies examining the broad impact of the aging population suggest an increasing demand on the overall urology work force, which, when coupled with a changing work force demographic, predicts a significant shortage that is only likely to worsen.

A national crisis over huge Veterans Administration backlogs in providing medical benefits to soldiers returning from Afghanistan and Iraq may be providing the platform for congressional consideration of legislation aimed at addressing urotrauma injuries incurred in combat.

The latest urology products and services from Olympus; Augmenix, Inc.; Cook Medical; SonaCare Medical; and Sony Electronics' Medical Systems Division.

In what is being called the largest clinical trial to examine the efficacy of poly(ADP-ribose) polymerases (PARP) inhibitor therapy in BRCA 1/2 carriers with diseases other than breast and ovarian cancer, the oral drug olaparib was found to be effective against advanced forms of both prostate and pancreatic cancer.

More intense surveillance and treatment in the first 2 years after a bladder cancer diagnosis could reduce the number of patients whose cancer recurs and lower the death rate from this disease, according to researchers from UCLA’s Jonsson Comprehensive Cancer Center.

Hitting all the highlights of an event as large as the AUA annual meeting is nearly impossible. But since returning home from San Diego, three topics have stuck with me as especially relevant.

Men using long-term, high-dose prescription opioids for back pain were about 50% more likely to be using medications for erectile dysfunction than men with back pain who were not using opioids, researchers reported.

Intensity-modulated radiation therapy may not be more effective than conformal radiation therapy in patients who have undergone radical prostatectomy, say researchers from the University of North Carolina, Chapel Hill.

Surveillance for cancer recurrence, rather than additional chemotherapy or radiation therapy, is sufficient for the vast majority of men who have undergone successful surgery for stage I seminoma, a long-term study suggests.

The effect of percutaneous tibial nerve stimulation in patients with overactive bladder appears to be durable at up to 3 years, a recently published study demonstrates.